Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Almudena Vega

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Nefrologia|November 24, 2018
High convective volumes are associated with improvement in metabolic profile in diabetic patients on online haemodiafiltrationNicolás Macías, Soraya Abad, Almudena Vega, et al.
The International Journal of Artificial Organs|September 21, 2024
Depurative capacity toward medium molecules of the dialyzer Toray NV-U<sup>®</sup> Hydrolink™: A new hydrophilic membrane to perform online hemodiafiltrationMaria Kislikova, Almudena Vega, Eduardo Verde, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 28, 2018
Removal capacity of different high-flux dialyzers during postdilution online hemodiafiltrationAlba Santos García, Nicolás Macías Carmona, Almudena Vega Martínez, et al.
Nefrologia|September 27, 2022
Is peritoneal dialysis suitable technique CKD patients over 65 years? A prospective multicenter studyJose Portolés, Almudena Vega, Enrique Lacoba, et al.
Plos One|May 29, 2015
Haematuria increases progression of advanced proteinuric kidney diseaseClaudia Yuste, Alfonso Rubio-Navarro, Daniel Barraca, et al.
Clinical Kidney Journal|April 17, 2020
The new marker YKL-40, a molecule related to inflammation, is associated with cardiovascular events in stable haemodialysis patientsAlmudena Vega, Maria Dolores Sanchez-Niño, Alberto Ortiz, et al.
The Journal of Vascular Access|September 23, 2015
The impact of access blood flow surveillance on reduction of thrombosis in native arteriovenous fistula: a randomized clinical trialInés Aragoncillo, Yésika Amézquita, Silvia Caldés, et al.
The Journal of Vascular Access|April 22, 2017
Adding access blood flow surveillance reduces thrombosis and improves arteriovenous fistula patency: a randomized controlled trialInés Aragoncillo, Soraya Abad, Silvia Caldés, et al.
Clinical Kidney Journal|November 2, 2023
Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltrationPatricia de Sequera, Rafael Pérez-García, Almudena Vega, et al.
Nefrologia|August 25, 2023
Peripheral arterial disease in hemodialysis patients 10 years laterÁngela González Rojas, Almudena Vega Martínez, Patrocinio Rodríguez Benítez, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Nefrologia|November 24, 2018
High convective volumes are associated with improvement in metabolic profile in diabetic patients on online haemodiafiltrationNicolás Macías, Soraya Abad, Almudena Vega, et al.
The International Journal of Artificial Organs|September 21, 2024
Depurative capacity toward medium molecules of the dialyzer Toray NV-U<sup>®</sup> Hydrolink™: A new hydrophilic membrane to perform online hemodiafiltrationMaria Kislikova, Almudena Vega, Eduardo Verde, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 28, 2018
Removal capacity of different high-flux dialyzers during postdilution online hemodiafiltrationAlba Santos García, Nicolás Macías Carmona, Almudena Vega Martínez, et al.
Nefrologia|September 27, 2022
Is peritoneal dialysis suitable technique CKD patients over 65 years? A prospective multicenter studyJose Portolés, Almudena Vega, Enrique Lacoba, et al.
Plos One|May 29, 2015
Haematuria increases progression of advanced proteinuric kidney diseaseClaudia Yuste, Alfonso Rubio-Navarro, Daniel Barraca, et al.
Clinical Kidney Journal|April 17, 2020
The new marker YKL-40, a molecule related to inflammation, is associated with cardiovascular events in stable haemodialysis patientsAlmudena Vega, Maria Dolores Sanchez-Niño, Alberto Ortiz, et al.
The Journal of Vascular Access|September 23, 2015
The impact of access blood flow surveillance on reduction of thrombosis in native arteriovenous fistula: a randomized clinical trialInés Aragoncillo, Yésika Amézquita, Silvia Caldés, et al.
The Journal of Vascular Access|April 22, 2017
Adding access blood flow surveillance reduces thrombosis and improves arteriovenous fistula patency: a randomized controlled trialInés Aragoncillo, Soraya Abad, Silvia Caldés, et al.
Clinical Kidney Journal|November 2, 2023
Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltrationPatricia de Sequera, Rafael Pérez-García, Almudena Vega, et al.
Nefrologia|August 25, 2023
Peripheral arterial disease in hemodialysis patients 10 years laterÁngela González Rojas, Almudena Vega Martínez, Patrocinio Rodríguez Benítez, et al.
Pageof 7